http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2482116-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bbce9f5b84a6267e416f9e6a11cf7b2 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4973 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4986 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-004 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-382 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-04 |
filingDate | 2009-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b137e8f1da837335cf707362123e47b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18476b5dd471feb2a57965fdbecda684 |
publicationDate | 2013-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2482116-C2 |
titleOfInvention | New 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosine kinase inhibitors, method for preparing them and using them in treating individuals, as well as in cosmetic products |
abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: present invention refers to new 4-(heterocycloalkyl)benzene-1,3-diol compounds described by general formula (I) presented below, wherein: R1, R2, R3 and R4 may be identical or different, and represent: - hydrogen,- C 1 -C 4 -alkyl radical,- hydroxymethyl, hydroxyethyl, - (C 1 -C 4 -alkoxy) carbonyl,- C 1 -C 4 -alkoxy,- hydroxyl, or R1 and R2 are bound to each other and to a carbon atom whereto attached to form a carbon cycle containing 5 or 6 carbon atoms, while R3 and R4 may be identical or different, and represent: - hydrogen, - C 1 -C 4 -alkyl radical, or R1 and R4 are bound to each other to form the chain -(CH 2 ) 2 - or -(CH 2 ) 3 -, while R2 and R3 may be identical or different, and represent: - hydrogen, - C 1 -C 4 -alkyl radical, X represents an oxygen atom or a sulphur atom, Y represents hydrogen, a chlorine atom or a fluorine atom, the value of m may represent 1 or 2, while the value of n may represent 0 or 1, and provided n=0, then m=1 or 2, and provided n=1, then m=1, as well as to salts of the compounds of general formula (I) and to their isomer and enantiomer forms. n EFFECT: invention relates to the use of these compounds in pharmaceutical or cosmetic compositions for the use in treating or preventing pigmentary disorders. n 7 cl, 2 tbl, 19 ex |
priorityDate | 2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 280.